发明名称 |
Angiogenic active lytic peptides |
摘要 |
This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The invention also relates to the use of such peptides in pharmaceutical compositions and in methods for treating diseases or disorders that are associated with angiogenic activity. |
申请公布号 |
US9487560(B2) |
申请公布日期 |
2016.11.08 |
申请号 |
US201313986434 |
申请日期 |
2013.05.02 |
申请人 |
ISSAR Pharmaceuticals Ltd |
发明人 |
Jaynes Jesse Michael |
分类号 |
A61K38/04;C07K7/08;C07K7/06 |
主分类号 |
A61K38/04 |
代理机构 |
|
代理人 |
Dodds John |
主权项 |
1. A lytic peptide fragment consisting of the amino acid sequence of FAKKFAKKFK (SEQ ID NO: 1), wherein the lytic peptide fragment inhibits angiogenesis. |
地址 |
Hyderabad IN |